<div id="readability-page-1"><div> By Katherine Hamilton <pre></pre> Micron Technology recorded a jump in sales and raised some of its expectations for demand growth in coming months. The stock gained 7.7%, to $242.86, in after-hours trading Wednesday. MillerKnoll's third-quarter forecast was ahead of Wall Street estimates. Shares rose 8.7%, to $19.05, after the bell. HireQuest authorized a $20 million share-buyback program. The stock rose 5%, to $8.12. Insmed said it would discontinue the development of its treatment for rhinosinusitis after the drug failed to meet primary and secondary endpoints. Shares slid 19%, to $160.18. <pre></pre> Write to Katherine Hamilton at katherine.hamilton@wsj.com <pre></pre> (END) Dow Jones Newswires December 17, 2025 18:50 ET (23:50 GMT)Copyright (c) 2025 Dow Jones &amp; Company, Inc.</div></div>

INSM

美光科技

MLKN

美光科技的销售增长导致股价上涨 7.7%。MillerKnoll 的预测超出预期，推动股价上涨 8.7%。HireQuest 宣布进行 2000 万美元的股票回购，股价上涨 5%。Insmed 停止了一项药物开发，导致股价下跌 19%

Stocks to Watch: Micron, MillerKnoll, HireQuest, Insmed

- Micron Technology 销售增长，预期需求改善，股价涨 7.7%，报 $242.86。  
- MillerKnoll 第三季度预测超出预期，股价涨 8.7%，报 $19.05。  
- Insmed 停止开发药物，股价跌 19%，报 $160.18。

值得关注的股票：美光科技、MillerKnoll、HireQuest、Insmed